Cite
HARVARD Citation
Tanaka, Y. et al. (n.d.). FRI0214 Long-term efficacy and safety of sirukumab in patients with active rheumatoid arthritis despite anti-tumor necrosis factor therapy: results of the randomized, phase 3 sirround-t study. Annals of the rheumatic diseases. pp. 563-564. [Online].